9.94
Lifemd Inc stock is traded at $9.94, with a volume of 1.10M.
It is down -4.51% in the last 24 hours and down -24.30% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$10.41
Open:
$10.14
24h Volume:
1.10M
Relative Volume:
0.56
Market Cap:
$451.75M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-15.53
EPS:
-0.64
Net Cash Flow:
$10.63M
1W Performance:
-7.02%
1M Performance:
-24.30%
6M Performance:
+78.46%
1Y Performance:
+48.58%
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LFMD
Lifemd Inc
|
9.94 | 458.57M | 193.06M | -22.51M | 10.63M | -0.64 |
![]()
VEEV
Veeva Systems Inc
|
281.35 | 46.88B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
54.89 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
91.06 | 8.54B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
DOCS
Doximity Inc
|
57.33 | 11.03B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
35.59 | 6.17B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-18-25 | Reiterated | BTIG Research | Buy |
Dec-10-24 | Initiated | Lake Street | Buy |
Dec-04-24 | Initiated | Mizuho | Neutral |
Aug-23-24 | Resumed | B. Riley Securities | Buy |
Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
Nov-30-23 | Initiated | Craig Hallum | Buy |
Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jul-03-23 | Initiated | H.C. Wainwright | Buy |
Mar-10-22 | Initiated | Colliers Securities | Buy |
Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
Is LifeMD Inc. stock overvalued or undervaluedFree Stock Ideas For Smart Trading - jammulinksnews.com
Does LifeMD Inc. stock perform well during market downturnsFree Stock Trend Scanner For 2025 - jammulinksnews.com
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare - TradingView
LifeMD's Strategic Leadership Upgrades and Their Implications for Sustained Growth in the Telehealth Sector - AInvest
LifeMD Names COO and Promotes Two Executives - GlobeNewswire
LifeMD appoints Shayna Webb Dray as chief operating officer - Investing.com Australia
Market Cool On LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Pushing Shares 26% Lower - 富途牛牛
LifeMD to Report Second Quarter 2025 Financial Results on August 5 - GlobeNewswire
LifeMD Inc. Recovery Potential Based on Technical ToolsConsistent Income Focused Trade List Analyzed - metal.it
LifeMD, Inc. to Report Q2 2025 Financial Results on August 5, 2025 - Quiver Quantitative
Watch for Bullish Crossover in LifeMD Inc.Low Risk Picks for Daily Trading Released - metal.it
What markets is LifeMD Inc. expanding into Is DSWL stock a good long term investment optionFinancial News Target Finder For Smart Trading - jammulinksnews.com
Discover LifeMD And 2 Other High Growth Stocks With Strong Insider Ownership - simplywall.st
How does LifeMD Inc. compare to its industry peersAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
What are the technical indicators suggesting about LifeMD Inc.Free Stock Index Interpretation - jammulinksnews.com
What are the latest earnings results for LifeMD Inc.Game-changing capital returns - jammulinksnews.com
What catalysts could drive LifeMD Inc. stock higher in 2025Get exclusive market insights for better trading - jammulinksnews.com
Is it the right time to buy LifeMD Inc. stockExceptional risk-adjusted gains - jammulinksnews.com
When is LifeMD Inc. stock expected to show significant growthGet expert analysis on top stock picks - jammulinksnews.com
Published on: 2025-07-27 22:12:27 - jammulinksnews.com
How does LifeMD Inc. generate profit in a changing economyUnlock powerful stock screening tools - jammulinksnews.com
What are LifeMD Inc. company’s key revenue driversExponentially increasing returns - jammulinksnews.com
How JPM.PRL stock compares to its top competitorsIs LifeMD Inc. stock undervalued or overvalued nowHigh-velocity capital appreciation - jammulinksnews.com
LifeMD Inc. Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional
What analysts say about LifeMD Inc. stockUnstoppable investment returns - Autocar Professional
Is LifeMD Inc. a good long term investmentFree Consultation - jammulinksnews.com
(LFMD) Proactive Strategies - news.stocktradersdaily.com
What drives LifeMD Inc. stock priceUnstoppable investment returns - jammulinksnews.com
Investing in LifeMD (NASDAQ:LFMD) three years ago would have delivered you a 364% gain - Yahoo Finance
LifeMD Q1 2025 presentation slides: Telehealth profitability surges amid 30% revenue growth - Investing.com Canada
Can LFMD sustain its earnings growth into Q1 2025? - AInvest
LifeMD Inc (LFMD) stock drops 4.41% on July 18, trading at $10.61, down from $11.10. Analysts forecast an average target price of $14.00, with a high estimate of $18.00 and a low estimate of $8.00. - AInvest
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifemd Inc Stock (LFMD) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Benathen Marc David | Chief Financial Officer |
Jun 16 '25 |
Sale |
13.09 |
75,000 |
981,945 |
389,554 |
Benathen Marc David | Chief Financial Officer |
Jun 17 '25 |
Sale |
14.01 |
50,000 |
700,495 |
339,554 |
Yecies Eric Harold | Chief Legal Officer & GC |
Jun 13 '25 |
Sale |
12.25 |
15,000 |
183,750 |
16,100 |
Galluppi Stefan | Chief Innovation Officer |
Jun 13 '25 |
Sale |
12.38 |
85,000 |
1,052,657 |
80,449 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):